Streetbeat News

Revenues

SPY

The USA Producer Price Index (PPI) for July came in at 2.2% year-over-year, slightly below the estimated 2.3% and down from the prior 2.7%.

Portfolio Pulse from Benzinga Newsdesk

August 13, 2024 | 12:30 pm

SPY

The Producer Price Index (PPI) for July increased by 0.1%, which is below the estimated 0.2%.

Portfolio Pulse from Benzinga Newsdesk

August 13, 2024 | 12:30 pm

SPY

The USA Core Producer Price Index (PPI) for July came in at 2.4% year-over-year, below the estimated 2.7% and the prior 3.0%.

Portfolio Pulse from Benzinga Newsdesk

August 13, 2024 | 12:30 pm

CSCI

COSCIENS Biopharma reported Q3 revenue of $2.3 million, a significant increase from $1.4 million year-over-year.

Portfolio Pulse from Benzinga Newsdesk

August 13, 2024 | 12:29 pm

NVDA

SOXX

TDIV

TSM

Taiwan Semiconductor Manufacturing Co (NYSE:TSM) is facing a severe workforce crisis that could hinder its AI growth, despite a 45% surge in July sales. The U.S. chip manufacturing workforce has significantly shrunk, and the demand for specialized workers is expected to rise sharply. This shortage could become a major bottleneck for TSM and the broader industry. TSM is a key supplier to Nvidia Corp (NASDAQ:NVDA), and investors can gain exposure through ETFs like iShares Semiconductor ETF (NASDAQ:SOXX) and First Trust NASDAQ Technology Dividend Index Fund (NASDAQ:TDIV).

Portfolio Pulse from Anusuya Lahiri

August 13, 2024 | 12:28 pm

MSC

Studio City Intl Hldgs (NYSE:MSC) reported a Q2 EPS of $(0.17), an improvement from $(0.25) YoY, and sales of $161.50M, up from $115.23M YoY.

Portfolio Pulse from Benzinga Newsdesk

August 13, 2024 | 12:27 pm

APVO

Aptevo Therapeutics has initiated a Phase 1b/2 RAINIER trial to evaluate its lead candidate Mipletamig (APVO436) in combination with Venetoclax and Azacitidine for frontline acute myeloid leukemia (AML). The new data from this trial is expected to bolster existing efficacy outcomes and identify the recommended Phase 2 dose.

Portfolio Pulse from Benzinga Newsdesk

August 13, 2024 | 12:27 pm

AKTS

Akoustis Technologies, Inc. (NASDAQ: AKTS) has received an additional $13 million purchase order for its XBAW RF filters from an existing Tier-1 customer, raising total production commitments to over $21 million. The customer also has the option to increase order quantities based on demand.

Portfolio Pulse from Benzinga Newsdesk

August 13, 2024 | 12:20 pm

GMGI

Golden Matrix Group reported Q2 earnings per share (EPS) of $0.00, down from $0.04 year-over-year (YoY). However, sales increased to $39.42 million from $22.58 million YoY.

Portfolio Pulse from Benzinga Newsdesk

August 13, 2024 | 12:17 pm

OXSQ

Oxford Square Capital (NASDAQ: OXSQ) reported Q2 2024 GAAP EPS of $0.13, meeting analyst expectations. However, sales of $11.445 million missed the $12.000 million estimate and were down 15.30% year-over-year.

Portfolio Pulse from Benzinga Newsdesk

August 13, 2024 | 12:17 pm